Theriva Biologics, Inc.
TOVX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000894158
No open-market purchases or sales by Theriva Biologics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $495.5K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Theriva Biologics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 33 | 26 | −7 |
| SharesConverted for a 1-for-10 split | 1.18M | 1.16M | −17.1K (−1.4%) |
| Value | $2.51M | $1.15M | −$1.36M (−54.2%) |
New holders (3)
Institutions that held Theriva Biologics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 56,077 | $55.0K | 0.00% |
| Bridgeway Capital Management, LLC | 28,528 | $28.0K | 0.00% |
| Virtu Financial LLC | 12,447 | $12.0K | 0.00% |
Sold out (10)
Institutions that held Theriva Biologics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Truist Financial Corp | 1,200,029 | $256.0K |
| Two Sigma Investments, LP | 161,373 | $34.0K |
| MSD Partners, L.P. | 116,430 | $25.0K |
| Victory Capital Management Inc | 22,035 | $5.00K |
| Landmark Financial Advisors, LLC | 23,000 | $5.00K |
| Jacobi Capital Management LLC | 18,500 | $4.00K |
| 1620 Investment Advisors, Inc. | 15,000 | $3.00K |
| Creative Planning | 10,000 | $2.00K |
| FMR LLC | 1,099 | $0 |
| BNP Paribas Arbitrage, SA | 1 | $0 |